3-{5,6-dichloro-1-[(2,6-dichlorophenyl)methyl]-1H-1,3-benzodiazol-2-yl}-1,2-dihydropyridin-2-one

Catalog No. :
ACJLYH939
CAS No. :
338774-41-7
Molecular Formula :
C19H11Cl4N3O
Molecular Weight :
439.13

IUPAC Name:3-(5,6-dichloro-1-(2,6-dichlorobenzyl)-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one

3-{5,6-dichloro-1-[(2,6-dichlorophenyl)methyl]-1H-1,3-benzodiazol-2-yl}-1,2-dihydropyridin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-{5,6-dichloro-1-[(2,6-dichlorophenyl)methyl]-1H-1,3-benzodiazol-2-yl}-1,2-dihydropyridin-2-one
IUPAC Name3-(5,6-dichloro-1-(2,6-dichlorobenzyl)-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one
MDL No.MFCD00244853
Molecular FormulaC19H11Cl4N3O
Molecular Weight439.13
SMILESO=C1C(C2=NC3=CC(Cl)=C(Cl)C=C3N2CC4=C(Cl)C=CC=C4Cl)=CC=CN1
InChI KeyPCGYFJBNYXMFBX-UHFFFAOYSA-N
Synonym3-[5,6-DICHLORO-1-(2,6-DICHLOROBENZYL)-1H-1,3-BENZIMIDAZOL-2-YL]-2(1H)-PYRIDINONE;3-{5,6-dichloro-1-[(2,6-dichlorophenyl)methyl]-1H-1,3-benzodiazol-2-yl}-1,2-dihydropyridin-2-one;2(1H)-Pyridinone, 3-[5,6-dichloro-1-[(2,6-dichlorophenyl)methyl]-1H-benzimidazol-2-yl]-
CAS No.338774-41-7

Synthetic Route by SureRoute

1. ACJLYH939 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYCZQ856 route compound structure diagram
    ACYCZQ856609-71-2 In Stock
  4. Then
  5. ACJLYH939 route product structure diagram
    ACJLYH939338774-41-7
Inquiry

2. ACJLYH939 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTIKF594 route compound structure diagram
    ACTIKF59415258-73-8 In Stock
  4. Then
  5. ACJLYH939 route product structure diagram
    ACJLYH939338774-41-7
Inquiry

Comments (0)